[go: up one dir, main page]

Ragab et al., 2020 - Google Patents

Role of levan extracted from bacterial honey isolates in curing peptic ulcer: In vivo

Ragab et al., 2020

View PDF
Document ID
15834080468538509929
Author
Ragab T
El Awdan S
El-Bassyouni G
Salama B
Helmy W
Esawy M
et al.
Publication year
Publication venue
International journal of biological macromolecules

External Links

Snippet

Peptic ulcer is one of the worldwide diseases where 10% of adults are affected by peptic ulcers at least once in their lifetime. The goal of this study was to evaluate the effect of levan in treating peptic ulcer. The bacterial honey isolates called Bacillus sp. levan was utilized …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Ragab et al. Role of levan extracted from bacterial honey isolates in curing peptic ulcer: In vivo
Abdhul et al. Antioxidant activity of exopolysaccharide from probiotic strain Enterococcus faecium (BDU7) from Ngari
Liu et al. Salidroside alleviates dextran sulfate sodium-induced colitis in mice by modulating the gut microbiota
Qi et al. Effects of Schisandra chinensis polysaccharides on rats with antibiotic-associated diarrhea
JP6954563B2 (en) Use of pasteurized Akkermansia to treat metabolic disorders
CN101048168B (en) Probiotic lactobacillus strains for improved vaginal health
Bai et al. Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota
KR101164876B1 (en) Broccoli production fermented by lactic acid bacteria, which is anti-inflammatory and anti-Helicobacter pylori and method for preparation thereof
Guo et al. In vitro digestion and fecal fermentation of Siraitia grosvenorii polysaccharide and its impact on human gut microbiota
EP3812452A1 (en) Bifidobacterium lactis bl-99 and application thereof
EP3808357B1 (en) Composition comprising megamonas funiformis and anaerofustis stercorihominis and use thereof
Duan et al. Role of gastric microorganisms other than helicobacter pylori in the development and treatment of gastric diseases
JP2021526856A (en) C. Difficile treatment method and composition
CN113832077A (en) Lactobacillus rhamnosus and application thereof
EP4442806A1 (en) Akkermansia guangxiensis capable of resisting oxidation, reducing fat and inhibiting tumor growth, and product and use thereof
Ran et al. Preventive effect of Chinese dwarf cherry [Cerasus humilis (Bge.) Sok.] fermentation juice on dextran sulfate sodium-induced ulcerative colitis rats through the regulation of IgA and the intestinal immune barrier
Wang et al. Potential prebiotic properties of exopolysaccharides produced by a novel Lactobacillus strain, Lactobacillus pentosus YY-112
JPS62145026A (en) Anticarcinogenic agent
CN117323298A (en) Bifidobacterium longum freeze-dried preparation, preparation method and application thereof
KR102244008B1 (en) A composition for preventing, improving or treating gliadin-induced inflammatory bowel disease of the comprising heat-killed lactobacillus paracasei glu70 as an active ingredient having gluten degradation activity
He et al. Changes in polyphenol fractions and bacterial composition after in vitro fermentation of apple peel polyphenol by gut microbiota
Zhang et al. Chimonanthus nitens Oliv polysaccharides modulate immunity and gut microbiota in immunocompromised mice
KR20200000956A (en) Compositions for Treatment or Prevention of Intestinal Diseases Comprising Propionibacterium freudenreichii, it culture broth or heat killed Propionibacterium freudenreichii as an active ingredient
CN116875507A (en) Application of Fusion of Weissella J4-1 and its Extracellular Polysaccharide in the Prevention and Treatment of Colon Cancer
Deshkar et al. In vitro and in vivo evaluation of prebiotic potential of pectin on vaginal lactobacilli